November/December 2010, Vol 3, No 6

Regulatory

Implications of the New Political Realities on Healthcare Reform
Interview with Dan Mendelson

Clinical

Engaging Providers in Medication Adherence: A Health Plan Case Study
Amy B. Scott, BSPharm, RPh
; Jane E. McClure, BA, RN
Stakeholder Perspective by F. Randy Vogenberg, PhD, RPh

Business

The H-E-B Value-Based Health Management Program: Impact on Asthma Medication Adherence and Healthcare Cost
Anna O. D’Souza, PhD
; Roshan Rahnama, MPH
; Timothy S. Regan, BPharm, RPh
; Beth Common, MBA
; Steven Burch, PhD
Stakeholder Perspective by Richard F. Radzin, PharmD

Industry Trends

Moving Beyond Good Intentions: Making Collaborative Care a Successful Reality
Gordon Norman, MD, MBA

Generic Drug Trends

Generics “Pipeline” Predicts Continued Market Share Gains Through 2014
Dalia Buffery, MA, ABD

AMCP HIGHLIGHTS

Cost May Not Drive Formulary Choice After All
Method Used to Measure MPR Influences Adherence Rate
Pharmacists’ Monitoring of ESAs Leads to Cost¬Savings
Adding a Pharmacist to a Medical Home May Cut Costs
Step-Therapy Program to Lower Rx Costs, Keep Members Happy
Disease State Impacts Medication Adherence
Targeting Waste in Targeted Therapies